๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Growth Hormone (GH) Treatment in Achondroplasia

โœ Scribed by Masamichi OGAWA; Osamu MORI; Toshi ASAI


Book ID
118715975
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
417 KB
Volume
34
Category
Article
ISSN
0914-3505

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Growth hormone therapy in achondroplasia
โœ Horton, William A. ;Hecht, Jacqueline T. ;Hood, O. Jean ;Marshall, Robert N. ;Mo ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 451 KB ๐Ÿ‘ 2 views

A pilot study was carried out to examine the safety and efficacy of recombinant human growth hormone for growth-promoting therapy of achondroplasia. The data suggest that the agent in doses used to treat non-GH-deficient forms of short stature (0.3 mg/kg/wk) modestly increases overall height velocit

Human growth hormone treatment in prepub
โœ Weber, Giovanna; Prinster, Chiara; Meneghel, Marta; Russo, Fiorella; Mora, Stefa ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 3 views

We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2'!'12 to 85/12 years and the GH dose was of 0.1 IU/kg/ day subcutaneously. Auxological assessments and bone age determinations were performed 6 mont